Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer. Clin Genitourin Cancer 2017 02;15(1):e95-e97 PMID: 27641657

Pubmed ID

27641657

DOI

10.1016/j.clgc.2016.08.006

Author List

Flynn T, Guancial EA, Kilari M, Kilari D

Author

Deepak Kilari MD Assistant Professor in the Medicine department at Medical College of Wisconsin




Scopus

2-s2.0-84994708562   3 Citations

MESH terms used to index this publication - Major topics in bold

Abiraterone Acetate
Drug Antagonism
Humans
Male
Middle Aged
Neoplasm Metastasis
Phenylthiohydantoin
Prostatic Neoplasms, Castration-Resistant
Spironolactone
Treatment Outcome
jenkins-FCD Prod-310 bff9d975ec7f2d302586822146c2801dd4449aad